See more : Tomita Electric Co.,Ltd. (6898.T) Income Statement Analysis – Financial Results
Complete financial analysis of Community Health Systems, Inc. (CYH) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Community Health Systems, Inc., a leading company in the Medical – Care Facilities industry within the Healthcare sector.
You may be interested
- Farm Pride Foods Limited (FRM.AX) Income Statement Analysis – Financial Results
- Compucase Enterprise Co., Ltd. (3032.TW) Income Statement Analysis – Financial Results
- Alset Capital Acquisition Corp. (ACAX) Income Statement Analysis – Financial Results
- Intense Technologies Limited (INTENTECH.NS) Income Statement Analysis – Financial Results
- Shaanxi Broadcast & TV Network Intermediary(Group)Co.,Ltd. (600831.SS) Income Statement Analysis – Financial Results
Community Health Systems, Inc. (CYH)
About Community Health Systems, Inc.
Community Health Systems, Inc. owns, leases, and operates general acute care hospitals in the United States. It offers general acute care, emergency room, general and specialty surgery, critical care, internal medicine, obstetrics, diagnostic, psychiatric, and rehabilitation services, as well as skilled nursing and home care services. The company also provides outpatient services at primary care practices, urgent care centers, free-standing emergency departments, ambulatory surgery centers, imaging and diagnostic centers, retail clinics, and direct-to-consumer virtual health visits. As of December 31, 2021, it owned or leased 83 hospitals, including 81 general acute care hospitals and two stand-alone rehabilitation or psychiatric hospitals with an aggregate of 13,289 licensed beds. The company was founded in 1985 and is headquartered in Franklin, Tennessee.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 12.49B | 12.21B | 12.37B | 11.79B | 13.21B | 14.16B | 15.35B | 18.44B | 19.44B | 18.64B | 13.00B | 13.03B | 11.91B | 11.40B | 12.11B | 10.84B | 7.13B | 4.37B | 3.74B | 3.33B | 2.83B | 2.20B | 1.69B | 1.34B | 1.08B |
| Cost of Revenue | 7.41B | 7.31B | 7.28B | 7.37B | 8.10B | 8.74B | 10.05B | 11.64B | 12.04B | 11.48B | 8.21B | 8.08B | 1.83B | 1.77B | 6.53B | 5.85B | 3.84B | 2.25B | 1.93B | 1.74B | 912.80M | 1.38B | 323.81M | 259.47M | 209.08M |
| Gross Profit | 5.08B | 4.91B | 5.08B | 4.42B | 5.11B | 5.42B | 5.31B | 6.80B | 7.40B | 7.16B | 4.79B | 4.95B | 10.07B | 9.63B | 5.58B | 4.99B | 3.29B | 2.11B | 1.80B | 1.59B | 1.92B | 817.99M | 1.37B | 1.08B | 870.87M |
| Gross Profit Ratio | 40.69% | 40.18% | 41.11% | 37.45% | 38.70% | 38.26% | 34.55% | 36.90% | 38.06% | 38.41% | 36.82% | 38.00% | 84.60% | 84.46% | 46.08% | 46.08% | 46.13% | 48.42% | 48.25% | 47.80% | 67.80% | 37.17% | 80.88% | 80.60% | 80.64% |
| Research & Development | 80.00M | 85.00M | 108.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 319.00M | 317.00M | 308.00M | 327.00M | 321.00M | 337.00M | 394.00M | 450.00M | 457.00M | 434.00M | 287.41M | 272.83M | 5.83B | 5.50B | 247.13M | 4.56B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 319.00M | 317.00M | 308.00M | 327.00M | 321.00M | 337.00M | 394.00M | 450.00M | 457.00M | 434.00M | 287.41M | 272.83M | 5.83B | 5.50B | 247.13M | 4.56B | 2.49B | 1.54B | 1.23B | 1.10B | 1.49B | 1.84B | 1.06B | 825.29M | 683.96M |
| Other Expenses | 3.73B | 3.70B | 3.35B | 2.91B | 3.91B | 4.19B | 4.70B | 5.28B | 5.53B | 5.24B | 3.50B | 3.47B | 4.89B | 4.60B | 4.26B | 1.71B | 316.22M | 191.57M | 167.67M | 158.26M | 145.75M | 120.45M | 119.67M | 97.62M | 81.65M |
| Operating Expenses | 4.13B | 4.01B | 3.66B | 3.24B | 4.23B | 4.53B | 5.09B | 5.73B | 5.99B | 5.68B | 3.78B | 3.74B | 9.00B | 8.51B | 4.51B | 9.86B | 2.80B | 1.73B | 1.40B | 1.25B | 1.63B | 1.96B | 1.18B | 922.92M | 765.61M |
| Cost & Expenses | 11.53B | 11.32B | 10.94B | 10.62B | 12.33B | 13.27B | 15.14B | 17.36B | 18.03B | 17.16B | 12.00B | 11.82B | 10.84B | 10.28B | 11.04B | 9.86B | 6.64B | 3.99B | 3.33B | 2.99B | 2.54B | 1.96B | 1.50B | 1.18B | 974.70M |
| Interest Income | 2.00M | 2.00M | 3.00M | 3.00M | 3.00M | 7.00M | 11.00M | 0.00 | 0.00 | 0.00 | 2.98M | 0.00 | 4.65M | 1.76M | 3.56M | 7.06M | 8.18M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 832.00M | 858.00M | 885.00M | 1.03B | 1.04B | 976.00M | 931.00M | 962.00M | 973.00M | 972.00M | 615.15M | 622.93M | 649.06M | 653.68M | 648.96M | 658.98M | 364.53M | 102.30M | 94.61M | 77.86M | 71.09M | 62.86M | 94.55M | 0.00 | 0.00 |
| Depreciation & Amortization | 505.00M | 534.00M | 540.00M | 558.00M | 608.00M | 700.00M | 861.00M | 1.10B | 1.17B | 1.19B | 782.68M | 725.56M | 657.67M | 609.84M | 566.54M | 506.69M | 332.58M | 188.77M | 166.16M | 158.38M | 143.77M | 118.22M | 119.67M | 97.62M | 81.65M |
| EBITDA | 1.54B | 1.74B | 1.93B | 2.02B | 1.23B | 970.00M | -1.00B | 307.00M | 2.57B | 2.42B | 1.63B | 1.86B | 1.78B | 1.77B | 1.66B | 1.53B | 824.19M | 569.23M | 571.70M | 500.85M | 434.54M | 359.73M | 308.71M | 252.74M | 186.91M |
| EBITDA Ratio | 12.36% | 11.79% | 16.07% | 14.78% | 11.39% | 11.37% | 7.11% | 12.03% | 13.61% | 14.57% | 14.05% | 15.18% | 14.54% | 15.13% | 13.72% | 13.75% | 11.86% | 13.04% | 15.29% | 14.94% | 15.33% | 16.35% | 18.23% | 18.90% | 17.31% |
| Operating Income | 957.00M | 821.00M | 1.40B | 1.13B | 896.00M | 208.00M | -1.88B | -860.00M | 1.34B | 1.38B | 899.76M | 1.21B | 1.13B | 1.11B | 1.07B | 983.57M | 485.69M | 380.46M | 405.53M | 338.87M | 290.77M | 241.51M | 189.04M | 155.11M | 105.26M |
| Operating Income Ratio | 7.66% | 6.72% | 11.34% | 9.55% | 6.78% | 1.47% | -12.23% | -4.66% | 6.88% | 7.40% | 6.92% | 9.29% | 9.53% | 9.78% | 8.83% | 9.07% | 6.81% | 8.72% | 10.85% | 10.17% | 10.26% | 10.98% | 11.16% | 11.60% | 9.75% |
| Total Other Income/Expenses | -750.00M | -472.00M | -903.00M | -704.00M | -1.08B | -923.00M | -955.00M | -855.00M | -926.00M | -997.00M | -611.14M | -706.35M | -660.94M | -606.49M | -622.54M | -607.34M | -378.39M | -104.10M | -94.61M | -72.44M | -71.09M | -62.86M | -94.55M | -127.37M | -116.49M |
| Income Before Tax | 207.00M | 349.00M | 499.00M | 422.00M | -430.00M | -715.00M | -2.83B | -1.72B | 411.00M | 342.00M | 305.86M | 503.77M | 473.55M | 508.43M | 446.13M | 336.14M | 102.90M | 278.16M | 310.92M | 260.22M | 219.68M | 178.65M | 94.50M | 27.74M | -11.24M |
| Income Before Tax Ratio | 1.66% | 2.86% | 4.03% | 3.58% | -3.26% | -5.05% | -18.45% | -9.30% | 2.11% | 1.83% | 2.35% | 3.87% | 3.98% | 4.46% | 3.68% | 3.10% | 1.44% | 6.37% | 8.32% | 7.81% | 7.75% | 8.12% | 5.58% | 2.07% | -1.04% |
| Income Tax Expense | 191.00M | 170.00M | 131.00M | -185.00M | 160.00M | -11.00M | -449.00M | -104.00M | 116.00M | 82.00M | 88.59M | 157.50M | 137.65M | 159.99M | 141.33M | 129.48M | 43.00M | 106.68M | 120.78M | 102.00M | 88.21M | 73.39M | 45.94M | 18.17M | 5.55M |
| Net Income | -133.00M | 179.00M | 368.00M | 511.00M | -590.00M | -788.00M | -2.46B | -1.72B | 158.00M | 92.00M | 141.20M | 265.64M | 201.95M | 279.98M | 243.15M | 218.30M | 30.29M | 168.26M | 167.54M | 151.43M | 131.47M | 99.98M | 44.74M | 9.57M | -16.79M |
| Net Income Ratio | -1.06% | 1.47% | 2.98% | 4.33% | -4.47% | -5.57% | -16.02% | -9.33% | 0.81% | 0.49% | 1.09% | 2.04% | 1.70% | 2.46% | 2.01% | 2.01% | 0.42% | 3.85% | 4.48% | 4.54% | 4.64% | 4.54% | 2.64% | 0.72% | -1.55% |
| EPS | -1.02 | 1.39 | 2.90 | 4.42 | -5.19 | -6.99 | -22.00 | -15.55 | 1.38 | 0.82 | 1.51 | 2.98 | 2.24 | 3.05 | 2.68 | 2.34 | 0.32 | 1.77 | 1.89 | 1.58 | 1.34 | 1.02 | 0.51 | 0.14 | -0.31 |
| EPS Diluted | -1.02 | 1.38 | 2.82 | 4.38 | -5.19 | -6.99 | -22.00 | -15.54 | 1.37 | 0.82 | 1.51 | 2.96 | 2.23 | 3.01 | 2.66 | 2.32 | 0.32 | 1.75 | 1.79 | 1.51 | 1.30 | 1.00 | 0.50 | 0.14 | -0.31 |
| Weighted Avg Shares Out | 130.39M | 128.81M | 126.75M | 115.49M | 113.74M | 112.73M | 111.77M | 110.71M | 114.00M | 112.00M | 92.63M | 89.24M | 89.97M | 91.72M | 90.62M | 93.37M | 93.52M | 94.98M | 88.60M | 95.64M | 98.39M | 98.42M | 88.38M | 67.61M | 54.55M |
| Weighted Avg Shares Out (Dil) | 130.45M | 130.06M | 130.60M | 116.54M | 113.74M | 112.73M | 111.77M | 110.73M | 115.00M | 113.00M | 93.82M | 89.81M | 90.67M | 92.95M | 91.52M | 94.29M | 94.64M | 96.23M | 98.58M | 100.29M | 101.13M | 108.38M | 90.25M | 69.19M | 54.55M |
Compared to Estimates, Community Health Systems (CYH) Q2 Earnings: A Look at Key Metrics
While the top- and bottom-line numbers for Community Health Systems (CYH) give a sense of how the business performed in the quarter ended June 2024, it could be worth looking at how some of its key metrics compare to Wall...
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Community Health Systems, Inc. - CYH
NEW YORK , July 24, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Community Health Systems, Inc. ("Community Health" or the "Company") (NYSE: CYH). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
Community Health Systems (CYH) Reports Q2 Loss, Tops Revenue Estimates
Community Health Systems (CYH) came out with a quarterly loss of $0.17 per share versus the Zacks Consensus Estimate of a loss of $0.11. This compares to loss of $0.22 per share a year ago.
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Community Health Systems, Inc. - CYH
NEW YORK, NY / ACCESSWIRE / July 23, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Community Health Systems, Inc. ("Community Health" or the "Company") (NYSE:CYH). Such investors are advised to contact Danielle Peyton at [email protected]...
Can These 3 Hospital Stocks Beat Q2 Earnings Expectations?
Rising patient volumes, admission and occupancy levels are expected to have benefited hospital players in the second quarter, partly offset by higher costs. THC, UHS and CYH will release earnings on Jul 24.
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Community Health Systems, Inc. - CYH
NEW YORK, July 20, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Community Health Systems, Inc. (“Community Health” or the “Company”) (NYSE: CYH). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Community Health Systems, Inc. - CYH
NEW YORK , July 18, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Community Health Systems, Inc. ("Community Health" or the "Company") (NYSE: CYH). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Community Health Systems, Inc. - CYH
NEW YORK, NY / ACCESSWIRE / July 14, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Community Health Systems, Inc. ("Community Health" or the "Company") (NYSE:CYH). Such investors are advised to contact Danielle Peyton at [email protected]...
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Community Health Systems, Inc. - CYH
NEW YORK, July 12, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Community Health Systems, Inc. (“Community Health” or the “Company”) (NYSE: CYH). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Community Health Systems, Inc. - CYH
NEW YORK , July 10, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Community Health Systems, Inc. ("Community Health" or the "Company") (NYSE: CYH). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
Source: https://incomestatements.info
Category: Stock Reports